Document Detail


Clinical spectrum of fibroblast growth factor receptor mutations.
MedLine Citation:
PMID:  10425034     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
During the last few years, it has been demonstrated that some syndromic craniosynostosis and short-limb dwarfism syndromes, a heterogeneous group comprising of 11 distinct clinical entities, are caused by mutations in one of three fibroblast growth factor receptor genes (FGFR1, FGFR2, and FGFR3). The present review list all mutations described to date in these three genes and the phenotypes associated with them. In addition, the tentative phenotype-genotype correlation is discussed, including the most suggested causative mechanisms for these conditions.
Authors:
M R Passos-Bueno; W R Wilcox; E W Jabs; A L Sertié; L G Alonso; H Kitoh
Related Documents :
9107244 - Prevalence of pro250arg mutation of fibroblast growth factor receptor 3 in coronal cran...
15340364 - Genotyping in 46 patients with tentative diagnosis of treacher collins syndrome reveale...
20937124 - The non-syndromic familial thoracic aortic aneurysms and dissections maps to 15q21 locus.
8250524 - Molecular genetics in neurology.
18562254 - Genetic analysis reveals an intrinsic property of the germinal center b cells to genera...
24773614 - Genetics of upper and lower airway diseases in the horse.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Human mutation     Volume:  14     ISSN:  1059-7794     ISO Abbreviation:  Hum. Mutat.     Publication Date:  1999  
Date Detail:
Created Date:  1999-08-20     Completed Date:  1999-08-20     Revised Date:  2012-06-05    
Medline Journal Info:
Nlm Unique ID:  9215429     Medline TA:  Hum Mutat     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  115-25     Citation Subset:  IM    
Copyright Information:
Copyright 1999 Wiley-Liss, Inc.
Affiliation:
Departamento Biologia, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil. passos@usp.br
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bone Diseases, Developmental / genetics
Genotype
Humans
Mutation / genetics*
Nervous System Malformations / genetics
Phenotype
Point Mutation
Protein-Tyrosine Kinases*
Receptor Protein-Tyrosine Kinases / genetics*
Receptor, Fibroblast Growth Factor, Type 1
Receptor, Fibroblast Growth Factor, Type 2
Receptor, Fibroblast Growth Factor, Type 3
Receptors, Fibroblast Growth Factor / genetics*
Grant Support
ID/Acronym/Agency:
5P01-HD22657/HD/NICHD NIH HHS; M01-RR00425/RR/NCRR NIH HHS; R01-DE-11441/DE/NIDCR NIH HHS
Chemical
Reg. No./Substance:
0/Receptors, Fibroblast Growth Factor; EC 2.7.10.1/FGFR1 protein, human; EC 2.7.10.1/FGFR2 protein, human; EC 2.7.10.1/FGFR3 protein, human; EC 2.7.10.1/Protein-Tyrosine Kinases; EC 2.7.10.1/Receptor Protein-Tyrosine Kinases; EC 2.7.10.1/Receptor, Fibroblast Growth Factor, Type 1; EC 2.7.10.1/Receptor, Fibroblast Growth Factor, Type 2; EC 2.7.10.1/Receptor, Fibroblast Growth Factor, Type 3
Comments/Corrections
Erratum In:
Hum Mutat 2001 May;17(5):431

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Update of the androgen receptor gene mutations database.
Next Document:  Heterogeneity in granular corneal dystrophy: identification of three causative mutations in the TGFB...